Serratia Marcescens Antikörper

Produktnummer ABIN7865733

Der Maus Monoklonal anti-Serratia Marcescens Antikörper wird verwendet zum Nachweis von Serratia Marcescens in Proben von Serratia marcescens. Er wurde validiert für IF, ELISA, ICC und IHC.

Kurzübersicht für Serratia Marcescens Antikörper (ABIN7865733)

Target: Serratia Marcescens

Reaktivität: Serratia marcescens

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Serratia Marcescens Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC), Immunohistochemistry (IHC)

Klon: EBS-I-105

Produktdetails anti-Serratia Marcescens Antikörper

Verwendungszweck: anti-Serratia marcescens mouse monoclonal, EBS-I-105, purified

Aufreinigung: affinity chromatography

Immunogen: total sonicate of Serratia marcescens

Isotyp: IgG3 kappa

Anwendungsinformationen

Applikationshinweise:

ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)

IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)

elisa_dilution: assay dependent

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 100 μg/mL

Buffer: PBS with 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: store at 2 - 8 °C

Details zu Serratia Marcescens

Target: Serratia Marcescens

Substanzklasse: Species

Hintergrund: Serratia marcescens is a species of Gram-negative bacteria in the family Enterobacteriaceae. It is a broad host range pathogen, and is also capable of opportunistic infections of humans. Some strains of S. marcescens are capable of producing a pigment called prodigiosin, which ranges in color from dark red to pale pink. S. marcescens is a rod shaped, motile organism and can grow in temperatures ranging from 5 - 40°C Celsius and in pH levels ranging from 5 to 9. S. marcescens is involved in hospital-acquired infections, particularly in urinary tract and wound infections. Serratia species cause 1.4% of nosocomial bloodstream infections with an associated mortality of 25% [in USA]. Most S. marcescens strains are resistant to several antibiotics because of the presence of R factors in plasmids. Positive control: S. marcescens extract or infected cells or tissue.